Stem Cell Assay Market - Forecast(2024 - 2030)

Stem Cell Assay Market size is estimated to reach $2.9 billion by 2027, growing at a CAGR of 19.4% during the forecast period 2022-2027. Stem cell assay indicates the technique of assessing the effectiveness of antineoplastic medications on the basis of their capacity of hindering the development of human tumor cells. The assay includes qualitative or quantitative investigation or experiment of affected tissues and tumors, wherein their toxicity, impurity, and added facets are examined. Cellular differentiation is the technique in which a cell alters from one cell type to another. Normally, the cell alters to a more specific kind. As part of the Stem Cell Differentiation Service, human induced pluripotent stem cells (hiPSCs) possess the capability to increase considerably and to make a distinction into all cell types of the human body. Correspondingly, they offer an infinite reservoir of hard-to-source cell types and can therefore assist in establishing greatly physiological models cells. Neural stem cells (NSCs) are self-rejuvenating, multipotent cells that basically produce the radial glial progenitor cells that generate the neurons and glia of the nervous system of all animals at the time of embryonic development. The Human Neural Stem Cell Characterization Kit developed by Sigma-Aldrich includes three molecular markers, Nestin, Sox 2 & Musashi that are time and again utilized to recognize neural stem/progenitor cells. An apoptosis assay discovers and measures the cellular events related to programmed cell death, involving caspase activation, cell surface exposure of phosphatidylserine (PS), and DNA fragmentation. With a professional scientific team and progressive procedure platform, Creative Bioarray can offer high-quality cell apoptosis assays to expedite the research and drug development project of the client. Comprehension of cell function is crucial to cellular research. Thermo Fisher Scientific provides an extensive series of cell function assays and reagents to decode key cellular techniques inclusive of apoptosis, cell proliferation, cell cycle and viability, oxidative stress, internalization techniques like phagocytosis, and endocytosis, and indicators for ion homeostasis.

The proliferating development of end-users for stem cells research products like biotechnology and biopharmaceutical industries is set to drive the Stem Cell Assay Market. The increased introduction of novel products in different sectors like cell function assays and financing in stem cell-based therapies is set to propel the growth of the Stem Cell Assay Market during the forecast period 2022-2027. This represents the Stem Cell Assay Industry Outlook.

Report Coverage

The report: “Stem Cell Assay Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Stem Cell Assay Market.

By Assay Type: Cell Viability And Toxicity Assays, Purification Assays, Differentiation Assays, Function Assays, Identification Assays, Proliferation Assays, Cell Apoptosis Assays.
By Cell Type: Adult Stem Cells, Human Embryonic Stem Cells (HESCs).
By Product: Instruments (Flow Cytometer, Cell Imaging Systems, Microelectrode Arrays, Automated Cell Counter), Detection Kits (Immunohistochemistry Kits).
By Application: Regenerative Medicine, Therapy Development, Drug Discovery And Development, Clinical Research.
By End User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Others.
By Geography: North America (the U.S, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Rest of South America) and Rest Of The World (Middle East, Africa).

Key Takeaways

• Geographically, North America Stem Cell Assay Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of incessant ailments involving the application of cell differentiation and the boost in the population of the elderly in the North American region.
• Stem Cell Assay Market growth is being driven by the assortment of stem cell applications in regenerative medicine, cell differentiation, and their role in the recognition of toxic agents with comparable toxicity. However, the dearth of needed infrastructure in developing economies and the soaring cost of the products are some of the major factors hampering the growth of the Stem Cell Assay Market.
• Stem Cell Assay Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Stem Cell Assay Market report.
  
  

  Stem Cell Assay Market: Market Share (%) by Region, 2021

  

Stem Cell Assay Market Segment Analysis – By Assay Type:

The Stem Cell Assay Market based on assay type can be further segmented into Cell Viability And Toxicity Assays, Purification Assays, Differentiation Assays, Function Assays, Identification Assays, Proliferation Assays, and Cell Apoptosis Assays. The Cell Viability And Toxicity Assays Segment held the largest market share in 2021. This growth is owing to the surging application of Cell Viability And Toxicity Assays in stem cell research activities. Stem cell differentiation is assuming importance currently. The role of cell viability assays in deciding the complete health of cells, making cell culture procedures perfect, and assessing cell survival after treatment with experimental stimuli or compounds are further propelling the growth of this segment.

Furthermore, the Cell Apoptosis Assays segment is estimated to grow with the fastest CAGR of 19.9% during the forecast period 2022-2027 owing to the increased application of cell apoptosis assays in cell biology like assessing the extent and timing of apoptosis by checking key cellular events in programmed cell death, like DNA fragmentation in TUNEL, GSH depletion, and caspase-3 activation and cell differentiation.

Stem Cell Assay Market Segment Analysis – By Application:

The Stem Cell Assay Market based on the application can be further segmented into Regenerative Medicine, Therapy Development, Drug Discovery And Development, and Clinical Research. The Regenerative Medicine Segment held the largest market share in 2021. This growth is owing to the expansions witnessed in the regenerative medicine sector. The capability of stem cells to self-renew and give rise to consequent generations with varying degrees of differentiation capacities provides the important possibility for the generation of tissues that can possibly substitute diseased and damaged areas in the body, with the nominal hazard of rejection and side effects. The increasing applications of stem cell differentiation are further propelling the growth of this segment.

Furthermore, the Drug Discovery And Development segment is estimated to grow with the fastest CAGR of 20.3% during the forecast period 2022-2027 owing to the proliferating demand for regenerative medicine and stem cell differentiation in conjunction with the provision of more secure and affordable medications.

Stem Cell Assay Market Segment Analysis – By Geography:

The Stem Cell Assay Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Stem Cell Assay Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the proliferating governmental initiatives backing stem cell-based research in the region. The onset of progressive technology like stem cell differentiation, the existence of key players like Biotechne Corporation developing innovative products, and increasing awareness regarding stem cell assays are propelling the growth of the Stem Cell Assay Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like advancement in the clinical research sector and the surging patient pool in the region. The burgeoning stem cell research resulting in the development of stem cell differentiation and expenditure in the biotechnology sector in conjunction with extensive healthcare infrastructure is fuelling the progress of the Stem Cell Assay Market in the Asia-Pacific region.

Stem Cell Assay Market Drivers

Increased Application Of Stem Cell Research Is Projected To Drive The Growth Of Stem Cell Assay Market:

Research into the reprogramming of somatic cells into pluripotent stem cells was awarded the Nobel Prize in 2012. The lasting significance of this research lies in the utilization of stem cells for regenerative therapies for the interim. However, these cells depict a possible indefinite source of greatly physiologically relevant cells, connected to human primary cells, that may be utilized as drug discovery reagents. The technique of differentiating stem cells into the somatic cell of preference is a lengthy procedure needing careful culturing. The technique normally uses immunofluorescence procedures to decide progenitor cells and terminally differentiated somatic cells. The Agilent BioTek imaging products with liquid handling and Agilent BioTek BioSpa 8 automated CO2 incubator have been planned to allow automated stem cell differentiation. The surging application of stem cell research resulting in automated stem cell differentiation is therefore fuelling the growth of the Stem Cell Assay Market during the forecast period 2022-2027.

Technological Innovations Are Expected To Boost The Demand Of Stem Cell Assays Market:

Technological innovations are driving the growth of the Stem Cell Assay market. Stem Cell Research delves into stem cell differentiation. R&D Systems, a biotech brand, has developed standardized all-in-one Stem Cell Differentiation Kits and media supplements for effective and recreating able stem cell differentiation, involving optimized cocktails of development determinants and tiny molecules. The kits include a marker antibody to confirm stem cell differentiation status including approved, simple, and effortless techniques. The StemXVivo® Differentiation Kits provide researchers the favorable chance to directly differentiate embryonic stem and induced pluripotent stem cells into an assortment of intermediate and terminally differentiated cell types, inclusive of Ectoderm, Mesoderm, Endoderm, Neural Progenitors, Cardiomyocytes, Oligodendrocytes, and Dopaminergic Neurons. These kinds of technological advancements are driving the growth of the Stem Cell Assay Market during the forecast period 2022-2027.

Stem Cell Assay Market Challenges

Challenges Encompassing The Compliance And Variety Of Stem Cell Assays In Hight Throughput Screening (HTS) Are Hampering The Growth Of The Stem Cell Assays Market:

The discrepancy between embryonic stem cell models, like mouse Embryonic Stem Cells (mESCs) versus human Embryonic Stem Cells (ESCs) is demanding. Even with the most recent procedures utilizing nuclear transfer cloning and fusion with ES cells, the hardships persist. The hardships in conjunction with the dearth of ailment applicable models for numerous ailments, propelled the creation of induced pluripotent stem cells (iPSCs) with the eventual goal to resolve the detected basic issues with stem cells. The production of iPSCs from mouse embryonic and adult fibroblasts was performed by introducing four factors: Oct3/4, Sox2, Klf4, and c-Myc6. The establishment of iPSCs permitted numerous to work with ailment applicable models and opened a complete novel avenue in stem cell research. Not only do iPSCs offer an ailment applicable model, but iPSCs are also readily compliant to HTS. However, the addition of the maintenance determinants renders the cell models genomically unstable. Thus, the question arises as to if there is truly a future for small molecules in personalized medicine based on either hESCs or iPSCs. These issues are hampering the growth of the Stem Cell Assays Market.

Stem Cell Assay Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Stem Cell Assay Market. Key companies of this market are:

1. Merck
2. Thermo Fisher Scientific
3. Promega Corporation
4. Bio-Techne Corporation
5. GE Healthcare
6. Stemcell Technologies
7. HemoGenix
8. Cellular Dynamics International (Cdi)
9. Bio-Rad Laboratories
10. Perkinelmer

Acquisitions/Product Launches:

• In September 2021, Promega Corporation introduced its OncoMate™ MSI Dx Analysis System (OncoMate™ MSI) in vitro diagnostic (IVD) in the U.S., providing oncologists and pathologists a novel alternative to examine and look for Lynch syndrome in patients with colorectal cancer. OncoMate™ MSI was authorized by the US Food and Drug Administration (FDA) last month as an IVD medical device to conclude on microsatellite instability (MSI) status in colorectal cancer tumors. OncoMate™ MSI is based on Promega technology that has been a gold standard worldwide for the last 15 years for examining MSI status in solid tumors.
• In June 2021, Thermo Fisher Scientific, the global chief in serving science, declared the introduction of a novel CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0. extends Thermo Fisher's menu of greatly precise tests that discover active SARS-CoV-2 contaminations.
• In March 2021, Thermo Fisher Scientific declared the kick-off of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a tailor-made menu of 22 confirmed real-time PCR assays for recognition of SARS-CoV-2 alterations. These assays allow surveillance of variants that are bringing about COVID-19 contaminations in particular regions worldwide and permit laboratories to select which mutations to track.
  

Related Reports

Stem Cell Therapies Market - Forecast(2021 - 2026)
Report Code: HCR 0384

Stem Cell Banking Market
Report Code: HCR 0459

For more Lifesciences and Healthcare Market reports, please click here